Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Find out the waiting period for credit card bonus rewards. Being informed can help you anticipate your benefits better.
15,727 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...
A longtime investor reevaluates the urge to claim Social Security at 62, choosing to wait for bigger monthly checks a...
Multicoin Capital disclosed a substantial Zcash position, triggering a double-digit rally in ZEC. The move underscore...
Coinbase announced a 14% workforce cut to accelerate a lean, AI-native operating model amid ongoing crypto market vol...
May 2026 brings a packed streaming slate as platforms roll out new originals and surprises, shaping market chatter ar...
Advantage (ADV) stunned some on the street with the Q2 2025 numbers, while others saw a path to steady growth. This d...
Bitcoin climbs past $80,000 on renewed ETF demand and institutional buying. Analysts map potential paths for BTC and ...
Alphabet’s Q1 2026 results show a rapid profit pace that dwarfs Meta’s earnings, underscoring a widening gap in AI-dr...
A notable move in a clean energy ETF raised questions: does a big sale signal trouble or discipline in a fast-growing...
Oil futures rose late Thursday as tensions in the Persian Gulf flared again, while stock-market futures were muted af...
The U.S. labor market produced a modest April gain, with the economy added 115,000 jobs and unemployment steady at 4....